Financial Data and Key Metrics Changes - In Q3 2025, the company's revenue was $2 million, a 24% decrease from $2.5 million in Q3 2024, primarily due to a timing reduction in iHP services sales from a key customer [9][10] - Year-to-date service demand remains robust, with quote activity and pipeline volume up approximately 35% year-over-year in life sciences and food safety [10] - Gross profit margins remained strong at 61% for Q3 2025, consistent with the same period last year [10] Business Line Data and Key Metrics Changes - Recurring BIT solution sales increased by 21% year-to-date, contributing to the overall revenue growth [5][10] - The sales order backlog was $0.9 million at the quarter end and grew to $1.3 million by October 31, with approximately $3 million in pending SteraMist integration contracts expected to close before year-end [6][10] Market Data and Key Metrics Changes - The FDA's broadened approval of hydrogen peroxide positions the company to serve not only life sciences and healthcare but also agriculture, food processing, and environmental biosafety [7][23] - The active pipeline surpassed $15 million, encompassing both domestic and international customers across various industries [6] Company Strategy and Development Direction - The company aims to enhance customer engagement and expand its recurring revenue streams through personalized outreach and targeted marketing campaigns [8] - Focus on biosecurity advancements and scaling automation integrations for high-efficacy environments is prioritized for 2026 [8][9] - The company is investing in innovation and customer success to capture opportunities in clean tech and biosecurity [7][8] Management's Comments on Operating Environment and Future Outlook - Management expressed optimism about the company's recovery and reaffirmed the soundness of its strategy, with steady improvement expected financially, operationally, and strategically [25][26] - The company is well-positioned for a successful fourth quarter with momentum carrying into 2026, supported by a recent equity purchase agreement to access capital [26][27] Other Important Information - The company celebrated a significant addition to its customer roster with Bausch + Lomb, which adopted mobile handheld surface units and committed to BIT Solution orders for 2026 [19][20] - The company is actively pursuing the cannabis market and has opened doors to promising new partnership discussions [22] Q&A Session Summary Question: What are your sales and marketing efforts towards the FDA approval for hydrogen peroxide usage? - Management indicated that the food industry could be a key marketing vertical, and they are excited about the approval as it positions their technology favorably [29] Question: Should we expect operating expenses and gross margins to continue improving? - Management expects operating expenses to increase but remain positive in relation to revenue, with gross margins expected to hold steady [30][31] Question: What kind of sales effort is in place for international markets like Morocco? - The company has distributors in various countries and is working with global partners to increase demand for SteraMist [34] Question: Do you have visibility on solution sales in the coming quarters? - Management noted that while there was a decrease in solution sales growth in Q3, they expect a rebound by the end of the fourth quarter [35] Question: Any updates on servicing military and defense markets? - Management mentioned ongoing studies with a key site looking to replace formaldehyde, with expectations for significant developments in 2026 [42] Question: Any progress in the use of SteraMist for replacing ethylene oxide in medical sterilization? - Management confirmed ongoing discussions and prioritization of partnerships in device manufacturing for this purpose [51]

Core Insights - TOMI Environmental Solutions, Inc. has formed a strategic alliance with Steri-Clean to enhance its franchise-focused growth strategy and address increasing biohazard challenges in the U.S. [1] - The adoption of SteraMist iHP technology by Steri-Clean aims to improve service offerings in hoarding cleanup and biohazard remediation, leveraging advanced disinfection solutions [1][2] - Steri-Clean operates approximately 60 franchises and is recognized for its expertise in handling complex cleaning scenarios, including severe clutter and hazardous materials [2] - The initial implementation of SteraPak units at Steri-Clean's franchise locations is expected to enhance service efficiency and effectiveness in disinfection [3] - The partnership aligns with TOMI's broader commercial strategy, which includes educational initiatives and customer support enhancements to tackle emerging public health issues [4] Company Overview - TOMI Environmental Solutions, Inc. specializes in disinfection and decontamination solutions, utilizing its Binary Ionization Technology® (BIT™) platform [4] - The BIT™ solution employs a low percentage of hydrogen peroxide as its active ingredient, utilizing patented ionized Hydrogen Peroxide (iHP™) technology for superior disinfection [4] - TOMI's products are designed for a wide range of applications, including hospitals, biosafety labs, commercial buildings, and emergency services [4]

Core Insights - TOMI Environmental Solutions, Inc. has announced a new service provider that will utilize its SteraMist iHP technology for mold and mycotoxins remediation in the healthcare sector, with an investment of approximately $185,500 in SteraMist mobile systems and BIT solution [1] - The new provider has secured a significant contract to remediate a 400,000-cubic-feet space at a hospital, which includes HVAC decontamination [1] - The partnership is expected to enhance TOMI's presence in the healthcare industry, leveraging the expertise of the new provider and its relationship with Enviro-Mist Inc., a long-standing partner specializing in mold remediation [2] Company Overview - TOMI Environmental Solutions, Inc. is a global company focused on decontamination and infection prevention, offering environmental solutions through its Binary Ionization Technology (BIT) platform [3] - BIT solution, developed under a defense grant with DARPA, utilizes a low percentage of hydrogen peroxide as its active ingredient and employs patented ionized Hydrogen Peroxide (iHP) technology for superior disinfection [3] - TOMI's products are applicable in various settings, including hospitals, biosafety labs, pharmaceutical facilities, and commercial buildings [3]

Company Overview - TOMI Environmental Solutions, Inc. specializes in disinfection and decontamination solutions, focusing on the life sciences sector with its SteraMist Integration System – Standalone (SIS-SA) [1][4] - The company utilizes its proprietary Binary Ionization Technology® (BIT™) platform, which employs ionized Hydrogen Peroxide (iHP™) for superior disinfection [5] Industry Insights - The life science sterility testing market is projected to grow to $3.4 billion by 2031, with a compound annual growth rate (CAGR) of 12.4%, driven by increased demand for pharmaceutical and biotechnology products and stricter regulatory standards [2][4] - Aseptic isolators are becoming increasingly critical as life sciences organizations aim to meet stringent regulatory requirements for sterile drug production [2] Product Development and Market Position - The first installation of the SIS-SA system marks a significant milestone for TOMI, indicating the company's commitment to expanding its presence in the life sciences industry [4] - A leading pharmaceutical CDMO has adopted TOMI's SteraMist iHP technology, indicating growing acceptance and investment in TOMI's solutions within the industry [3][4] - The company anticipates generating over half a million dollars in revenue from the SIS-SA product in fiscal 2025, reflecting strong market demand [4]

Core Insights - TOMI Environmental Solutions, Inc. has been awarded the "Disinfection and Decontamination Products Company of the Year 2025" by MedTech Outlook, showcasing its commitment to excellence and customer trust in its SteraMist iHP technology [1][2][3] Company Overview - TOMI Environmental Solutions, Inc. specializes in disinfection and decontamination solutions, utilizing its proprietary Binary Ionization Technology® (BIT™) platform, which employs a low percentage of hydrogen peroxide as the active ingredient [4] - The SteraMist systems incorporate patented ionized Hydrogen Peroxide (iHP™) technology, providing superior disinfection across various sectors, including healthcare, pharmaceuticals, and food processing [4] Recognition and Commitment - The award selection involved an expert panel of C-level executives and industry leaders, affirming SteraMist's leadership in the disinfection and decontamination market for 2025 [2] - The CEO of TOMI expressed gratitude for the recognition, emphasizing the company's dedication to advancing its iHP technology and exceeding customer expectations globally [3]

Core Insights - TOMI Environmental Solutions, Inc. has successfully deployed its SteraMist iHP technology at NASA Johnson Space Center, marking its entry into the aerospace sector [1][2] - The technology is being utilized in a biosafety cabinet for handling samples from the Mars Perseverance Rover mission, demonstrating its application in space exploration [2][3] - This deployment is part of TOMI's strategic SteraMistX campaign, which aims to enhance biosecurity standards in aerospace and military fields [4] Company Overview - TOMI Environmental Solutions, Inc. is a global leader in disinfection and decontamination solutions, utilizing technology developed through DARPA [1][5] - The company's primary product, the Binary Ionization Technology (BIT) platform, employs a low percentage of hydrogen peroxide as its active ingredient, providing superior disinfection capabilities [5] - TOMI's products are designed for a wide range of environments, including hospitals, biosafety labs, pharmaceutical facilities, and more [5]